2025-02-012026-01-312026-01-31false14057953Beverley House Dispensary Ltd2026-09-14falseiso4217:GBPxbrli:pure140579532025-01-31140579532026-01-31140579532025-02-012026-01-31140579532024-01-31140579532025-01-31140579532024-02-012025-01-3114057953bus:SmallEntities2025-02-012026-01-3114057953bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3114057953bus:FullAccounts2025-02-012026-01-3114057953bus:PrivateLimitedCompanyLtd2025-02-012026-01-3114057953core:WithinOneYear2026-01-3114057953core:AfterOneYear2026-01-3114057953core:WithinOneYear2025-01-3114057953core:AfterOneYear2025-01-3114057953core:ShareCapital2026-01-3114057953core:SharePremium2026-01-3114057953core:RevaluationReserve2026-01-3114057953core:OtherReservesSubtotal2026-01-3114057953core:RetainedEarningsAccumulatedLosses2026-01-3114057953core:ShareCapital2025-01-3114057953core:SharePremium2025-01-3114057953core:RevaluationReserve2025-01-3114057953core:OtherReservesSubtotal2025-01-3114057953core:RetainedEarningsAccumulatedLosses2025-01-3114057953core:LandBuildings2026-01-3114057953core:PlantMachinery2026-01-3114057953core:Vehicles2026-01-3114057953core:FurnitureFittings2026-01-3114057953core:OfficeEquipment2026-01-3114057953core:NetGoodwill2026-01-3114057953core:IntangibleAssetsOtherThanGoodwill2026-01-3114057953core:ListedExchangeTraded2026-01-3114057953core:UnlistedNon-exchangeTraded2026-01-3114057953core:LandBuildings2025-01-3114057953core:PlantMachinery2025-01-3114057953core:Vehicles2025-01-3114057953core:FurnitureFittings2025-01-3114057953core:OfficeEquipment2025-01-3114057953core:NetGoodwill2025-01-3114057953core:IntangibleAssetsOtherThanGoodwill2025-01-3114057953core:ListedExchangeTraded2025-01-3114057953core:UnlistedNon-exchangeTraded2025-01-3114057953core:LandBuildings2025-02-012026-01-3114057953core:PlantMachinery2025-02-012026-01-3114057953core:Vehicles2025-02-012026-01-3114057953core:FurnitureFittings2025-02-012026-01-3114057953core:OfficeEquipment2025-02-012026-01-3114057953core:NetGoodwill2025-02-012026-01-3114057953core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3114057953core:ListedExchangeTraded2025-02-012026-01-3114057953core:UnlistedNon-exchangeTraded2025-02-012026-01-3114057953core:MoreThanFiveYears2025-02-012026-01-3114057953core:Non-currentFinancialInstruments2026-01-3114057953core:Non-currentFinancialInstruments2025-01-3114057953dpl:CostSales2025-02-012026-01-3114057953dpl:DistributionCosts2025-02-012026-01-3114057953core:LandBuildings2025-02-012026-01-3114057953core:PlantMachinery2025-02-012026-01-3114057953core:Vehicles2025-02-012026-01-3114057953core:FurnitureFittings2025-02-012026-01-3114057953core:OfficeEquipment2025-02-012026-01-3114057953dpl:AdministrativeExpenses2025-02-012026-01-3114057953core:NetGoodwill2025-02-012026-01-3114057953core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3114057953dpl:GroupUndertakings2025-02-012026-01-3114057953dpl:ParticipatingInterests2025-02-012026-01-3114057953dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-3114057953core:ListedExchangeTraded2025-02-012026-01-3114057953dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-3114057953core:UnlistedNon-exchangeTraded2025-02-012026-01-3114057953dpl:CostSales2024-02-012025-01-3114057953dpl:DistributionCosts2024-02-012025-01-3114057953core:LandBuildings2024-02-012025-01-3114057953core:PlantMachinery2024-02-012025-01-3114057953core:Vehicles2024-02-012025-01-3114057953core:FurnitureFittings2024-02-012025-01-3114057953core:OfficeEquipment2024-02-012025-01-3114057953dpl:AdministrativeExpenses2024-02-012025-01-3114057953core:NetGoodwill2024-02-012025-01-3114057953core:IntangibleAssetsOtherThanGoodwill2024-02-012025-01-3114057953dpl:GroupUndertakings2024-02-012025-01-3114057953dpl:ParticipatingInterests2024-02-012025-01-3114057953dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-012025-01-3114057953core:ListedExchangeTraded2024-02-012025-01-3114057953dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-012025-01-3114057953core:UnlistedNon-exchangeTraded2024-02-012025-01-3114057953core:NetGoodwill2026-01-3114057953core:IntangibleAssetsOtherThanGoodwill2026-01-3114057953core:LandBuildings2026-01-3114057953core:PlantMachinery2026-01-3114057953core:Vehicles2026-01-3114057953core:FurnitureFittings2026-01-3114057953core:OfficeEquipment2026-01-3114057953core:AfterOneYear2026-01-3114057953core:WithinOneYear2026-01-3114057953core:ListedExchangeTraded2026-01-3114057953core:UnlistedNon-exchangeTraded2026-01-3114057953core:ShareCapital2026-01-3114057953core:SharePremium2026-01-3114057953core:RevaluationReserve2026-01-3114057953core:OtherReservesSubtotal2026-01-3114057953core:RetainedEarningsAccumulatedLosses2026-01-3114057953core:NetGoodwill2025-01-3114057953core:IntangibleAssetsOtherThanGoodwill2025-01-3114057953core:LandBuildings2025-01-3114057953core:PlantMachinery2025-01-3114057953core:Vehicles2025-01-3114057953core:FurnitureFittings2025-01-3114057953core:OfficeEquipment2025-01-3114057953core:AfterOneYear2025-01-3114057953core:WithinOneYear2025-01-3114057953core:ListedExchangeTraded2025-01-3114057953core:UnlistedNon-exchangeTraded2025-01-3114057953core:ShareCapital2025-01-3114057953core:SharePremium2025-01-3114057953core:RevaluationReserve2025-01-3114057953core:OtherReservesSubtotal2025-01-3114057953core:RetainedEarningsAccumulatedLosses2025-01-3114057953core:NetGoodwill2024-01-3114057953core:IntangibleAssetsOtherThanGoodwill2024-01-3114057953core:LandBuildings2024-01-3114057953core:PlantMachinery2024-01-3114057953core:Vehicles2024-01-3114057953core:FurnitureFittings2024-01-3114057953core:OfficeEquipment2024-01-3114057953core:AfterOneYear2024-01-3114057953core:WithinOneYear2024-01-3114057953core:ListedExchangeTraded2024-01-3114057953core:UnlistedNon-exchangeTraded2024-01-3114057953core:ShareCapital2024-01-3114057953core:SharePremium2024-01-3114057953core:RevaluationReserve2024-01-3114057953core:OtherReservesSubtotal2024-01-3114057953core:RetainedEarningsAccumulatedLosses2024-01-3114057953core:AfterOneYear2025-02-012026-01-3114057953core:WithinOneYear2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3114057953core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3114057953core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3114057953core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3114057953core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3114057953core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3114057953bus:Director12025-02-012026-01-3114057953bus:Director22025-02-012026-01-31

Beverley House Dispensary Ltd

Registered Number
14057953
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

Beverley House Dispensary Ltd
Company Information
for the year from 1 February 2025 to 31 January 2026

Directors

Mrs Smita Dutta
Dr Abhishek Kabra

Registered Address

1 Beverley Road
Hessle
HU13 9AE

Registered Number

14057953 (England and Wales)
Beverley House Dispensary Ltd
Statement of Financial Position
31 January 2026

Notes

2026

2025

£

£

£

£

Current assets
Debtors3-5,569
Cash at bank and on hand153243
1535,812
Creditors amounts falling due within one year4-(56,720)
Net current assets (liabilities)153(50,908)
Total assets less current liabilities153(50,908)
Net assets153(50,908)
Capital and reserves
Called up share capital100100
Profit and loss account53(51,008)
Shareholders' funds153(50,908)
The financial statements were approved and authorised for issue by the Board of Directors on 14 September 2026, and are signed on its behalf by:
Dr Abhishek Kabra
Director
Registered Company No. 14057953
Beverley House Dispensary Ltd
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The company ceased trading on 1 September 2026. Consequently, the directors have prepared the financial statements on a basis other than that of a going concern. In accordance with this basis, assets have been written down to their net realizable value and provisions have been made for any uncompleted and onerous contractual commitments, as at the balance sheet date. Provision has been made for the direct costs of terminating the operations of the company where a legal obligation existed. The financial statements do not include any adjustments relating to the reclassification of fixed assets to current assets, as values already reflect estimated residual recovery amounts. The company has no outstanding debts with the relevant tax agencies and the directors intend to strike off the company with companies house.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20262025
Average number of employees during the year22
3.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables-88
Other debtors-5,481
Total-5,569
4.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables-10,157
Amounts owed to related parties-46,563
Total-56,720
5.Related party transactions
During the year the directors loaned the company £NIL. This loan was interest free and repayable upon demand.
6.Exceptional items
During the year a non-trading loan amounting to £57,810 owed to Kabra Holdings Ltd was written off to £NIL. This loan was included within amounts owed to group undertakings in the balance sheet.
7.Parent-subsidiary relationships
Beverley House Dispensary Ltd is a wholly owned subsidiary of Kabra Holdings Ltd, which is the parent company of it's group.